Flow and tDCS Evidence Flow Overview Flow Webinars In-clinic Resources Marketing Materials

Flow & tDCS Evidence

Data Pack front cover
Flow Neuroscience
May, 2024

Summary of Flow evidence including safety, efficacy, and side effect information

NHS quant article may 2024
Griffiths, C., Maravic da Silva, K., Jiang, H., Smart, D., and Zafar, A.
May, 2024

Flow for Depression Treatment in a Primary Healthcare General Practice—Depression, Functioning, and Health-Related Quality of Life Outcomes

NHS Journal of Depression CMHT
Griffiths, C. , Walker, K. , Willis, A.
Feb, 2024

Qualitative Study Exploring the Experience and Value of Flow - Community Mental Health

NHS Journal of Depression GP
Griffiths, C. , Walker, K. , Jiang, H. , Noel-Johnson, A. and Zafar, A.
Nov, 2023

Qualitative Study Exploring the Experience and Value of Flow - Primary Care

Additional studies reviewing tDCS

tDCS antidepressant effects peak at 6 weeks
Nikolin et al.
Mar, 2023

tDCS antidepressant effects peak at around 6 weeks

Frengi et al. 2021
Frengi et al.
Jul, 2020

tDCS for depression is definitely effective (level A evidence)

Moffa et al. 2020
Moffa et al.
Apr, 2020

A meta-analysis: tDCS was an effective intervention in reducing depressive symptoms